Insulin aspart, recombinant Subcutaneous and Zolpidem Extended-Release Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zolpidem Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: zolpidem
Brand name: Ambien, Ambien CR, Edluar, Intermezzo, ZolpiMist
Synonyms: Zolpidem
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zolpidem Oral Spray
- Insulin aspart, recombinant Subcutaneous-Zolpidem Oral, Oromucosal
- Insulin aspart, recombinant Subcutaneous-Zolpidem Sublingual
- Insulin aspart, recombinant Subcutaneous-Zolpidem Sublingual Tablets (Edluar)
- Insulin aspart, recombinant Subcutaneous-Zolpidem Sublingual Tablets (Intermezzo)
- Insulin aspart, recombinant Subcutaneous-Zolpidem Tablets
- Zolpidem Extended-Release Tablets-Insulin degludec
- Zolpidem Extended-Release Tablets-Insulin Degludec (U-100) Prefilled Pens
- Zolpidem Extended-Release Tablets-Insulin Degludec (U-100) Vials
- Zolpidem Extended-Release Tablets-Insulin Degludec (U-200) Prefilled Pens
- Zolpidem Extended-Release Tablets-Insulin degludec and liraglutide
- Zolpidem Extended-Release Tablets-Insulin degludec and liraglutide Subcutaneous